esbriet 267 mg filmsko obložene tablete
roche registration ltd. - pirfenidon - filmsko obložena tableta - pirfenidon 267 mg / 1 tableta - pirfenidon
esbriet 801 mg filmsko obložene tablete
roche registration ltd. - pirfenidon - filmsko obložena tableta - pirfenidon 801 mg / 1 tableta - pirfenidon
tecentriq 1200 mg koncentrat za raztopino za infundiranje
roche registration gmbh - atezolizumab - koncentrat za raztopino za infundiranje - atezolizumab 1200 mg / 1 viala - -
hemlibra 150 mg/ml raztopina za injiciranje
roche registration ltd. - emicizumab - raztopina za injiciranje - emicizumab 150 mg / 1 ml - emicizumab
hemlibra 30 mg/ml raztopina za injiciranje
roche registration ltd. - emicizumab - raztopina za injiciranje - emicizumab 30 mg / 1 ml - emicizumab
hemlibra 150 mg/ml raztopina za injiciranje
roche registration ltd. - emicizumab - raztopina za injiciranje - emicizumab 150 mg / 1 ml - emicizumab
ocrevus 300 mg koncentrat za raztopino za infundiranje
roche registration gmbh - okrelizumab - koncentrat za raztopino za infundiranje - okrelizumab 300 mg / 10 ml - okrelizumab
hemlibra 150 mg/ml raztopina za injiciranje
roche registration ltd. - emicizumab - raztopina za injiciranje - emicizumab 150 mg / 1 ml - emicizumab
klopidogrel jenson 75 mg filmsko obložene tablete
jenson - klopidogrel - filmsko obložena tableta - klopidogrel 75 mg / 1 tableta - klopidogrel
libmeldy
orchard therapeutics (netherlands) bv - atidarsagene autotemcel - leukodystrophy, metachromatic - druga zdravila na živčnem sistemu - libmeldy is indicated for the treatment of metachromatic leukodystrophy (mld) characterized by biallelic mutations in the arysulfatase a (arsa) gene leading to a reduction of the arsa enzymatic activity:in children with late infantile or early juvenile forms, without clinical manifestations of the disease,in children with the early juvenile form, with early clinical manifestations of the disease, who still have the ability to walk independently and before the onset of cognitive decline.